Tongxinluo attenuates oxygen-glucose-serum deprivation/restoration-induced endothelial barrier breakdown via peroxisome proliferator activated receptor-α/angiopoietin-like 4 pathway in high glucose-incubated human cardiac microvascular endothelial cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tongxinluo attenuates oxygen-glucose-serum deprivation/restoration-induced endothelial barrier breakdown via peroxisome proliferator activated receptor-α/angiopoietin-like 4 pathway in high glucose-incubated human cardiac microvascular endothelial cells

Published:2020-08-21 Issue:34 Volume:99 Page:e21821
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Qi Kang,Yang Yuejin,Geng Yongjian,Cui Hehe,Li Xiangdong,Jin Chen,Chen Guihao,Tian Xiaqiu,Meng Xianmin

Funder

National Key Research and Development Project in China

National Basic Research Program (973 Program) in China

National Natural Science Foundation of China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference38 articles.

1. Myocardial infarction and the open-artery hypothesis;Hillis;N Engl J Med,2006

2. Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis;Tuo;Am J Physiol Heart Circ Physiol,2008

3. A PKC-beta inhibitor treatment reverses cardiac microvascular barrier dysfunction in diabetic rats;Wei;Microvasc Res,2010

4. A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy;Rangasamy;Invest Ophthalmol Vis Sci,2011

5. Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway;Mangialardi;Arterioscler Thromb Vasc Biol,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of traditional Chinese medicine in modulating cardiac microvascular endothelial cells in various injury models: A comprehensive systematic review;2024-09-08

2. Chinese patent medicine Tongxinluo: A review on chemical constituents, pharmacological activities, quality control, and clinical applications;Phytomedicine;2024-09

3. Tongxinluo capsule as a multi-functional traditional Chinese medicine in treating cardiovascular disease: A review of components, pharmacological mechanisms, and clinical applications;Heliyon;2024-07

4. Clinical effects and mechanisms of a Chinese patent medicine, Tongxinluo capsule, as an adjuvant treatment in coronary heart disease;Heliyon;2024-03

5. Molecular mechanisms and therapeutic perspectives of peroxisome proliferator‐activated receptor α agonists in cardiovascular health and disease;Medicinal Research Reviews;2023-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3